Nanalysis Scientific Corp.
NSCIF
$0.2215
$0.01175.58%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 50.53% | 3.71% | -22.07% | -64.72% | -146.82% |
| Total Depreciation and Amortization | -16.11% | 14.23% | 45.60% | 83.45% | -8.31% |
| Total Amortization of Deferred Charges | 1.71% | -24.33% | -49.94% | -75.52% | 43.39% |
| Total Other Non-Cash Items | 57.14% | 654.74% | 965.97% | 284.20% | 70.19% |
| Change in Net Operating Assets | 113.54% | 117.40% | 88.56% | 40.18% | -4.73% |
| Cash from Operations | 99.09% | 91.83% | 60.48% | -26.91% | -188.66% |
| Capital Expenditure | 63.36% | 85.51% | 83.69% | 67.62% | 82.93% |
| Sale of Property, Plant, and Equipment | -22.99% | -42.23% | -101.62% | -44.36% | 21.17% |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | 1.40% | -- | -- | -- | -- |
| Other Investing Activities | 48.32% | 45.61% | 1.78% | 47.54% | 52.05% |
| Cash from Investing | 47.06% | 42.61% | 18.93% | 48.73% | 58.69% |
| Total Debt Issued | -73.11% | -58.28% | 97.24% | 393.51% | 8,345.79% |
| Total Debt Repaid | 33.45% | -38.11% | -141.27% | -65.24% | -279.82% |
| Issuance of Common Stock | 7.13% | 7.03% | 5,960.87% | -71.51% | -71.75% |
| Repurchase of Common Stock | -1,900.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6,193.75% | -833.09% | -576.22% | -219.74% | 76.47% |
| Cash from Financing | -85.07% | -92.47% | 273.29% | 3.41% | -1.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 84.54% | 48.37% | 99.64% | 59.47% | -39.07% |